The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Simulation modeling of cost-savings from conversion of pegfilgrastim to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced (febrile) neutropenia (CIN/FN) and expanded access to biosimilar prophylaxis.
 
Ali McBride
Speakers' Bureau - Coherus BioSciences
 
Karen MacDonald
Consulting or Advisory Role - Celgene (Inst); Coherus BioSciences (Inst); Janssen Scientific Affairs (Inst); Novartis (Inst); Rockwell Medical (Inst); Sandoz (Inst); TERUMO (Inst)
Speakers' Bureau - Coherus BioSciences (I)
 
Ivo Abraham
Consulting or Advisory Role - Celgene (Inst); Coherus Biosciences (Inst); Janssen Scientific Affairs (Inst); Novartis (Inst); Rockwell Medical (Inst); Sandoz (Inst); TERUMO (Inst)
Speakers' Bureau - Coherus Biosciences (Inst)